Azelaic acid in the treatment of papulopustular rosacea: A systematic review of randomized controlled trials

Archives of Dermatology

Volumn 142, Issue 8, 2006, Pages 1047-1052

  Liu, Rosemarie H ^a,c   Smith, Molly K ^a,d   Basta, Sameh A ^a,b   Farmer, Evan R ^a,e,f,g  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b SENTARA HEALTHCARE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g 580 Mowbray Arch ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; FINACEA; FINEVIN; METRONIDAZOLE;

BIOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DRUG EFFICACY; DRUG FORMULATION; EMBASE; GEL; HUMAN; MEDICAL RECORD; MEDLINE; PAPULOPUSTULAR ROSACEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; ROSACEA; SKIN BURNING SENSATION; SKIN IRRITATION; SYSTEMATIC REVIEW;

ADMINISTRATION, CUTANEOUS; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; HUMANS; RANDOMIZED CONTROLLED TRIALS; ROSACEA; SEVERITY OF ILLNESS INDEX;

EID: 33747624395     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.8.1047     Document Type: Review

References (19)

1. Feature 3: rosacea takes emotional toll but many learn how to cope. Rosacea Review Newsletter, National Rosacea Society Web site, summer 1998. http://www.rosacea.org/RR/1998/summer/article_3.html. Accessed Summer 1998.
2. Wilkin JK. Rosacea: pathophysiology and treatment. Arch Dermatol. 1994;130:359-362.
3. Starr PAH, McDonald A. Oculocutaneous aspects of rosacea. Proc R Soc Med. 1969;62:9-11.
4. Marks R. Concepts in the pathogenesis of rosacea. Br J Dermatol. 1968;80:170-177.
5. Marks R, Jones EW. Disseminated rosacea. Br J Dermatol. 1969;81:16-28.
6. Marks R. Rosacea, flushing and perioral dermatitis. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology. Malden, Mass: Blackwell Scientific Publications; 1993:1851-1863.
7. Wilkin JK. Use of topical products for maintaining remission in rosacea. Arch Dermatol. 1999;135:79-80.
8. Nguyen QH, Bui TP. Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. Int J Dermatol. 1995;34:75-84.
9. Leeming JP, Holland KT, Bojar RA. The in vitro antimicrobial effect of azelaic acid. Br J Dermatol. 1986;115:551-556.
10. Fitton A, Goa KL. Azelaic acid: a review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs. 1991;41:780-798.
11. Breathnach AS. Pharmacological properties of azelaic acid. Clin Drug Invest. 1995;10(suppl 2):27-33.
12. Jadad AR, Moore RE, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
13. Bjerke R, Fyrand O, Graupe K. Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea. Acta Derm Venereol. 1999;79:456-459.
14. Carmichael A, Marks R, Graupe KA, et al. Topical azelaic acid in the treatment of rosacea. J Dermatol Treat. 1993;4(suppl 1):S19-S22.
15. Thiboutot D, Thieroff-Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol. 2003;48:836-845.
16. Elewski BE, Fleischer AB Jr, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea. Arch Dermatol. 2003;139:1444-1450.
17. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol. 1999;40:961-965.
18. Hebert AA. Azelaic acid 15% gel reduces the intensity of erythema in patients with moderate papulopustular facial rosacea: data from two phase 3 trials. Presented as a poster at: 61st Annual Meeting of the American Academy of Dermatology; March 21-26, 2003; San Francisco, Calif.
19. Thiboutot D, Graupe K, Lavin PT, Thieroff-Ekerdt R. A new static score to assess papulopustular (stage 2) rosacea: experience from 2 large, vehicle-controlled, phase 3 studies comparing a new azelaic acid 15% gel formulation with its vehicle. Presented as a poster at: 61st Annual Meeting of the American Academy of Dermatology; March 21-26, 2003; San Francisco, Calif.